European Journal of Human Genetics

Papers
(The median citation count of European Journal of Human Genetics is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Hitting the heights with CiteScore95
Germline NPAT inactivating variants as cause of hereditary colorectal cancer92
Utilization of automated cilia analysis to characterize novel INPP5E variants in patients with non-syndromic retinitis pigmentosa85
Benign splenic lesions in BAP1-tumor predisposition syndrome: a case series75
Defining ethical criteria to guide the expanded use of Noninvasive Prenatal Screening (NIPS): Lessons about severity from preimplantation genetic testing71
Ethical considerations for genetic research in low-income countries: perceptions of informed consent, data sharing, and expectations in Nicaragua69
Biallelic variants in genes previously associated with dominant inheritance: CACNA1A, RET and SLC20A267
Expectations, needs and mid-term outcomes in people accessing to secondary findings from ES: 1st French mixed study (FIND Study)66
Identification of biallelic POLA2 variants in two families with an autosomal recessive telomere biology disorder65
Metaplastic breast cancer and BRCA1: first strong evidence of a link64
“I just wanted more”: Hereditary cancer syndromes patients’ perspectives on the utility of circulating tumour DNA testing for cancer screening57
Perceptions of severity and their influence on reproductive decision-making following reproductive genetic carrier screening56
A unique service: how an embedded psychology team can help patients and genetics clinicians within a clinical genetics service54
Commentary on Eichinger J, Zimmermann B, Elger B, McLennan S, Filges I, Koné I. 2023. ‘It’s a nightmare’: informed consent in paediatric genome-wide sequencing. A qualitative expert interview study fr51
Panel testing for the molecular genetic diagnosis of congenital hypogonadotropic hypogonadism – a clinical perspective47
Preferences for genetic testing among populations underrepresented in genomic research: a systematic review46
The Young Geneticists Network and the ESHG-Young committee, a forward-looking international community42
Genotype of PAX2-related disorders correlates with kidney and ocular manifestations40
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters40
Ethics in editorship: lessons from a major retraction incident37
Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome36
Discovery of recessive effect of human polymerase δ proofreading deficiency through mutational analysis of POLD1-mutated normal and cancer cells36
The first genetically confirmed cohort of Facioscapulohumeral Muscular Dystrophy from Northern India35
Direct-to-consumer genetic testing: an updated systematic review of healthcare professionals’ knowledge and views, and ethical and legal concerns33
Johann Gregor Mendel: the victory of statistics over human imagination32
Correction: A framework for evaluating long-term impact of newborn screening32
Biallelic variants in the synaptic vesicle glycoprotein 2 A are associated with epileptic encephalopathy31
Börjeson–Forssman–Lehmann syndrome: delineating the clinical and allelic spectrum in 14 new families30
Contribution of common risk variants to multiple sclerosis in Orkney and Shetland30
Genetic and allelic heterogeneity in 248 Indians with skeletal dysplasia30
Exploring the ethics of genetic prioritisation for COVID-19 vaccines29
Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON28
Prevalence and natural history of schwannomas in neurofibromatosis type 2 (NF2): the influence of pathogenic variants27
Mapping pleiotropic loci using a fast-sequential testing algorithm27
Phenotypic subtypes of Xia-Gibbs syndrome: a latent class analysis26
30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes26
Two distinct mechanisms underlie estrogen-receptor-negative breast cancer susceptibility at the 2p23.2 locus26
Correction: Structural variant calling and clinical interpretation in 6224 unsolved rare disease exomes26
Identification and characterization of two DMD pedigrees with large inversion mutations based on a long-read sequencing pipeline25
Out now in May’s EJHG25
A polygenic risk score for multiple myeloma risk prediction25
A systematic review assessing the existence of pneumothorax-only variants of FLCN. Implications for lifelong surveillance of renal tumours24
Fond farewell to clinical utility gene cards24
An integrated multiomic approach as an excellent tool for the diagnosis of metabolic diseases: our first 3720 patients24
Investigation of a pathogenic inversion in UNC13D and comprehensive analysis of chromosomal inversions across diverse datasets23
Expansion of the neurodevelopmental phenotype of individuals with EEF1A2 variants and genotype-phenotype study23
Comment on Gustavson syndrome is caused by an in-frame deletion in RBMX associated with potentially disturbed SH3 domain interactions23
What’s new in genetics in June 2022?22
Osteopathia striata with cranial sclerosis: a new case supporting the link with bilateral Wilms tumor22
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics22
Correction: Slowly progressive autosomal dominant Alport Syndrome due to COL4A3 splicing variant22
Dutch pharmacogenetics working group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan22
Heterozygous and homozygous variants in STX1A cause a neurodevelopmental disorder with or without epilepsy21
Exome sequencing as first-tier genetic testing in infantile-onset pharmacoresistant epilepsy: diagnostic yield and treatment impact21
Solving unsolved rare neurological diseases—a Solve-RD viewpoint21
Correction: Phenotypic subtypes of Xia-Gibbs syndrome: a latent class analysis21
Importance of critical thinking to understand ChatGPT21
Koban culture genome-wide and archeological data open the bridge between Bronze and Iron Ages in the North Caucasus21
Episignature analysis of moderate effects and mosaics21
Attitudes of professional stakeholders towards implementation of reproductive genetic carrier screening: a systematic review20
Correction to: Toward the diagnosis of rare childhood genetic diseases: what do parents value most?20
Solving medical mysteries with genomics20
Prenatal Genome-Wide Sequencing analysis (Exome or Genome) in detecting pathogenic Single Nucleotide Variants in fetal Central Nervous System Anomalies: systematic review and meta-analysis19
Trio-based exome sequencing reveals a high rate of the de novo variants in intellectual disability19
Ribonuclease inhibitor 1 (RNH1) deficiency cause congenital cataracts and global developmental delay with infection-induced psychomotor regression and anemia19
Demolishing the silo: towards team-based genomics in primary care19
Correction: Genetic discrimination still casts a large shadow in 202218
New Insight into the genotype-phenotype correlation of PTH1R variants and primary failure of tooth eruption on an Italian Cohort18
Abstracts from the 57th European Society of Human Genetics (ESHG) Conference: Hybrid Posters18
Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study18
Regional autozygosity association with albumin-to-creatinine ratio reveals a novel FTO region in an Indigenous Australian population18
POLD3 haploinsufficiency is linked to non-syndromic sensorineural adult-onset progressive hearing and balance impairments18
Should testing for mosaic genome-wide paternal uniparental disomy in Beckwith-Wiedemann spectrum (BWSp) be implemented in diagnostic testing?17
Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan17
Recommendations for whole genome sequencing in diagnostics for rare diseases17
Comment on Informing relatives of their genetic risk: an examination of the Belgian context16
CHAMP1-related disorders: pathomechanisms triggered by different genomic alterations define distinct nosological categories16
Confirmation and expansion of the phenotype of the TCEAL1-related neurodevelopmental disorder16
Spring in EJHG16
Role of ZFHX4 in orofacial clefting based on human genetic data and zebrafish models16
A yeast based assay establishes the pathogenicity of novel missense ACTA2 variants associated with aortic aneurysms16
Comparing 2D and 3D representations for face-based genetic syndrome diagnosis16
A tiered strategy to identify relevant genetic variants in familial pulmonary fibrosis: a proof of concept for the clinical practice16
Correction: Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations16
Highly variable hearing loss due to POU4F3 (c.37del) is revealed by longitudinal, frequency specific analyses15
Consanguinity and willingness to perform premarital genetic screening in Sudan15
The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases15
Studying ultra-rare variants in STX1A uncovers a novel neurodevelopmental disorder15
A biallelic variant of DCAF13 implicated in a neuromuscular disorder in humans14
Genetics of diaphragmatic hernia14
Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations14
Correction: A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells14
“Hypothesis: Patient with possible disturbance in programmed cell death”: further insights in pathogenicity and clinical features of Fraser syndrome14
A rare genotype of biallelic mosaic variants in BCOR gene causing a bilateral ocular anterior segment dysgenesis and cataracts14
The natural history of adults with Rubinstein-Taybi syndrome: a families-reported experience14
A second hotspot for pathogenic exon-skipping variants in CDC4514
Quality of life, illness perceptions, and parental lived experiences in TANGO2-related metabolic encephalopathy and arrhythmias14
Correction: Solving unsolved rare neurological diseases—a Solve-RD viewpoint14
Assessing the contribution of genetic nurture to refractive error14
Correction: Expansion of the neurodevelopmental phenotype of individuals with EEF1A2 variants and genotype-phenotype study14
Assessing the unmet needs of genomic testing in Australia: a geospatial exploration13
Chromosome 20p11.2 deletions cause congenital hyperinsulinism via the loss of FOXA2 or its regulatory elements13
Negotiating severity behind the scenes: prenatal testing in Germany13
Pathogenic cryptic variants detectable through exome data reanalysis significantly increase the diagnostic yield in Joubert syndrome13
What is health and what do we mean when we say an intervention improves health?13
Germline variant in Ctcf links mental retardation to Wilms tumor predisposition13
Craniofrontonasal syndrome in a patient with an inv(X)(p22.2q13.1), separating EFNB1 from its enhancer13
Assessing the digenic model in rare disorders using population sequencing data13
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)13
Germline pathogenic variants in HNRNPU are associated with alterations in blood methylome13
Diagnostic outcome of pro bono neurogenetic diagnostic service in Sri Lanka: A wealth creation13
Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot13
What does a consent conversation for whole genome sequencing look like in the NHS Genomic Medicine Service? An observational study13
Copy number variants from 4800 exomes contribute to ~7% of genetic diagnoses in movement disorders, muscle disorders and neuropathies13
Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases13
Analysis of large-language model versus human performance for genetics questions13
Molecular investigation in individuals with orofacial clefts and microphthalmia-anophthalmia-coloboma spectrum13
Genome sequencing enables diagnosis and treatment of SLC5A6 neuropathy13
A family with ulcerative colitis maps to 7p21.1 and comprises a region with regulatory activity for the aryl hydrocarbon receptor gene13
The Spanish Polygenic Score reference distribution: a resource for personalized medicine12
Cascade screening for beta-thalassaemia in Pakistan: relatives’ experiences of a decision support intervention in routine practice12
Ten years of dynamic consent in the CHRIS study: informed consent as a dynamic process12
New year, new issue12
Knowledge, attitudes and demand toward cardiovascular polygenic risk testing in clinical practice: cross-sectional survey of patients12
Prioritization of disease genes from GWAS using ensemble-based positive-unlabeled learning12
Novel PUF60 variant suggesting an interaction between Verheij and Cornelia de Lange syndrome: phenotype description and review of the literature12
Correction to: Genetics etiologies and genotype phenotype correlations in a cohort of individuals with central conducting lymphatic anomaly12
Considering severity in the design of reproductive genetic carrier screening programs: screening for severe conditions12
Multilocus Inherited Neoplasia Allele Syndrome (MINAS): an update12
Risk perception and intended behavior change after uninformative genetic results for adult-onset hereditary conditions in unselected patients12
Allele frequency differentiation at height-associated SNPs among continental human populations12
Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres12
‘Diagnostic shock’: the impact of results from ultrarapid genomic sequencing of critically unwell children on aspects of family functioning12
Comparing saliva and blood for the detection of mosaic genomic abnormalities that cause syndromic intellectual disability12
Variable number tandem repeats (VNTRs) as modifiers of breast cancer risk in carriers of BRCA1 185delAG12
Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review12
Phenotypic compatibility and specificity in genomic variant classification11
Negotiating ‘severity’ in plain sight11
A tool for translating polygenic scores onto the absolute scale using summary statistics11
Clinical and genetic analysis further delineates the phenotypic spectrum of ALDH1A3-related anophthalmia and microphthalmia11
The cause of Jones syndrome put to REST: a mutation in the REST gene causes gingival fibromatosis and hearing loss11
The congenital hearing phenotype in GJB2 in Queensland, Australia: V37I and mild hearing loss predominates11
Mild phenotypes in patients with different deletions in the 3′ enhancer region of SHOX11
Becoming agents for genomic change: genetic counsellors’ views of patient care and implementation influences when genomics is mainstreamed11
Societal implications of expanded universal carrier screening: a scoping review11
Leave no one behind: inclusion of alpha-1 antitrypsin deficiency patients in COVID-19 vaccine trials11
An encounter with the mild side of LARS2-associated Perrault syndrome and its implications on the diagnostic odyssey11
Cascade screening for beta-thalassemia in Pakistan: development, feasibility and acceptability of a decision support intervention for relatives11
Refining clinically relevant parameters for mis-splicing risk in shortened introns with donor-to-branchpoint space constraint11
“I am not a number!” Opinions and preferences of people with intellectual disability about genetic healthcare11
Global trends and themes in genetic counseling research11
Microsatellite instability in gastrointestinal cancers11
Expanding the phenotypic spectrum of LIG4 pathogenic variations: neuro-histopathological description of 4 fetuses with stenosis of the aqueduct11
POT1 tumour predisposition: a broader spectrum of associated malignancies and proposal for additional screening program10
Improving diagnosis of mitochondrial fatty-acid oxidation disorders10
Early illustrations of the importance of systematic phenotyping10
Additive effect of frequent polymorphism and rare synonymous variant alters splicing in twin patients with Niemann-Pick disease type C10
GWAS of lipids in Greenlanders finds association signals shared with Europeans and reveals an independent PCSK9 association signal10
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Oral Presentations10
Returning individual research results in international direct-to-participant genomic research: results from a 31-country study10
Loss of function of ADNP by an intragenic inversion10
Exome sequencing of ATP1A3-negative cases of alternating hemiplegia of childhood reveals SCN2A as a novel causative gene10
GLA insufficiency should not be called Fabry disease10
Genomics elucidates both common and rare disease aetiology10
Genetic testing for monogenic forms of motor neuron disease/amyotrophic lateral sclerosis in unaffected family members10
Novel phenotype of SIN3A-related disorder diagnosed in adulthood with multi-system involvement10
The utility of population level genomic research9
Genomic Balancing Act: deciphering DNA rearrangements in the complex chromosomal aberration involving 5p15.2, 2q31.1, and 18q21.329
Are employees ready to engage in genetic cancer risk assessment in the workplace setting?9
Rare autosomal trisomies detected by non-invasive prenatal testing: an overview of current knowledge9
An analysis of genetically regulated gene expression and the role of co-expression networks across 16 psychiatric and substance use phenotypes9
Scientific refutation of ESHG statement on embryo selection9
Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis9
Clinical genomics testing: mainstreaming and globalising9
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women9
Pathogenic variants in PIDD1 lead to an autosomal recessive neurodevelopmental disorder with pachygyria and psychiatric features9
Knowledge, attitudes and decision regret: a longitudinal survey study of participants offered genome sequencing in the 100,000 Genomes Project9
Correction: A MT-TL1 variant identified by whole exome sequencing in an individual with intellectual disability, epilepsy, and spastic tetraparesis9
Comment on Future trends in clinical genetic and genomic services by Borle et al.9
ParseCNV2: efficient sequencing tool for copy number variation genome-wide association studies9
Combined approaches, including long-read sequencing, address the diagnostic challenge of HYDIN in primary ciliary dyskinesia9
Biallelic variants in CCN2 underlie an autosomal recessive kyphomelic dysplasia9
De novo variants underlying monogenic syndromes with intellectual disability in a neurodevelopmental cohort from India9
Somatic and germinal mosaicism in a Han Chinese family with laminopathies9
WDR45-related encephalopathy mimicking Leigh syndrome associated with complex I deficiency: a case report8
International transfers of personal data for health research following Schrems II: a problem in need of a solution8
Genetic counselling and testing for neurodegenerative disorders using a proposed standard of practice for ALS/MND: diagnostic testing comes first8
A novel in-frame GFAP p.E138_L148del mutation in Type II Alexander disease with atypical phenotypes8
ADAMTS1, MPDZ, MVD, and SEZ6: candidate genes for autosomal recessive nonsyndromic hearing impairment8
Genomic medicine in neonatal care: progress and challenges8
Predictive genetic testing for Motor neuron disease: time for a guideline?8
Genetic basis of osteogenesis imperfecta from a single tertiary centre in South Africa8
Emerging cancer risks in BRCA2 pathogenic germline variant carriers8
Reassessment of FBN1 variants of uncertain significance using updated ClinGen guidance for PP1/BS4 and PP4 criteria8
Should non-invasive prenatal testing (NIPT) be used for fetal sex determination? Perspectives and experiences of healthcare professionals8
Correction to: The stepwise process of integrating a genetic counsellor into primary care8
Correction to: Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases8
The stepwise process of integrating a genetic counsellor into primary care8
Diagnosis and management of vascular Ehlers-Danlos syndrome: Experience of the UK national diagnostic service, Sheffield8
Biallelic variants in RYR1 and STAC3 are predominant causes of King-Denborough Syndrome in an African cohort8
Genomic technologies identify milder presentations of Mendelian disease8
Host genetic basis of COVID-19: from methodologies to genes8
A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection8
Genetic diagnosis for rare diseases in the Dutch Caribbean: a qualitative study on the experiences and associated needs of parents8
Correction to: First-line exome sequencing in Palestinian and Israeli Arabs with neurological disorders is efficient and facilitates disease gene discovery8
LARS2 variants can present as premature ovarian insufficiency in the absence of overt hearing loss8
Rare-variant association analysis reveals known and new age-related hearing loss genes8
Australian human research ethics committee members’ confidence in reviewing genomic research applications8
Consent for genomic sequencing: a conversation, not just a form8
Workshop report: the clinical application of data from multiplex assays of variant effect (MAVEs), 12 July 20238
Down syndrome screening and diagnosis practices in Europe, United States, Australia, and New Zealand from 1990–20218
Incorporating patient perspectives in the development of a core outcome set for reproductive genetic carrier screening: a sequential systematic review7
A successful conclusion to the long search for TRPV5 pathogenic variants in monogenic hypercalciuria7
Tools to differentiate between Filamin C and Titin truncating variant carriers: value of MRI7
Genomic testing for rare disease diagnosis—where are we now, and where should we be heading? The reflections of a behavioural scientist7
Singleton exome sequencing of 90 fetuses with ultrasound anomalies revealing novel disease-causing variants and genotype–phenotype correlations7
Experiences of nonpregnant couples after receiving reproductive genetic carrier screening results in Belgium7
A new impact factor for EJHG in 20227
ADNP in reverse gear7
Beyond the hype: a comprehensive critique of ChatGPT’s applicability in genetics7
EMD missense variant causes X-linked isolated dilated cardiomyopathy with myocardial emerin deficiency7
Reanalysis of clinical exome identifies the second variant in two individuals with recessive disorders7
Somatic CAG repeat instability in intermediate alleles of the HTT gene and its potential association with a clinical phenotype7
The genetics of hereditary cancer risk syndromes in Brazil: a comprehensive analysis of 1682 patients7
Validity of European-centric cardiometabolic polygenic scores in multi-ancestry populations7
The genetic landscape and clinical implication of pediatric Moyamoya angiopathy in an international cohort7
Somatic genetic variation in healthy tissue and non-cancer diseases7
The interplay of ethics and genetic technologies in balancing the social valuation of the human genome in UNESCO declarations7
Research participants: critical friends, agents for change7
Missense mutation of MAL causes a rare leukodystrophy similar to Pelizaeus-Merzbacher disease7
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer7
IMPDH2: a new gene associated with dominant juvenile-onset dystonia-tremor disorder7
STRavinsky STR database and PGTailor PGT tool demonstrate superiority of CHM13-T2T over hg38 and hg19 for STR-based applications7
Reevaluating ‘seriousness’ in genetic conditions: balancing clinical criteria and lived experiences7
What’s new in EJHG in June 2024?7
Molecular explanations for variability of clinical phenotypes7
Novel insights into the consequences of obesity: a phenotype-wide Mendelian randomization study7
Good quality practices for artificial intelligence in genetics7
A novel nonsense variant in the CENPP gene segregates in a Swiss family with autosomal dominant low-frequency sensorineural hearing loss7
Public perspectives on healthcare professional-directed communication of hereditary genetic risks: a mixed-method systematic review7
Polygenic risk modeling for prediction of epithelial ovarian cancer risk7
Beyond severity: utility as a criterion for setting the scope of RGCS7
Two for the heart: Dutch Pharmacogenetic Working Group prescribing guidance on statins and sulfonylureas to reduce cardiometabolic risk7
Old and new challenges regarding comparable and viable data sharing in population-scale genomic research7
Publics’ knowledge of, attitude to and motivation towards health-related genomics: a scoping review7
Oro-dental phenotyping and report of three families with RELT-associated amelogenesis imperfecta7
KiT-GENIE, the French genetic biobank of kidney transplantation7
GenCOLT: a multicenter European biobank for investigating genome-wide determinants of lung transplant outcomes7
Contributing to the on-going debate around the clinical application of preimplantation embryo selection based on polygenic risk scores (PGT-P)7
XRCC4-related microcephalic primordial dwarfism: description of a clinical series of 7 cases, phenotype expansion and new diagnostic approaches7
0.10745406150818